<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02628158</url>
  </required_header>
  <id_info>
    <org_study_id>Kyorineye019</org_study_id>
    <nct_id>NCT02628158</nct_id>
  </id_info>
  <brief_title>Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane</brief_title>
  <official_title>Correlation of Postoperative Vision and Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyorin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyorin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fundus autofluorescence (FAF) at the macula originates from hyperfluorescence from retinal
      pigment epithelium (RPE) and blockage of hyperfluorescence by macular pigment. Investigators
      evaluate whether presence of FAF may correlate to the postoperative visual outcome for
      epiretinal membrane.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      92 eyes with epiretinal membrane were performed vitreous surgery, epiretinal membrane removal
      and internal limiting membrane (ILM) peeling. Presence of hyperfluorescence in FAF at the
      macular area and best-corrected visual acuity (BCVA) was evaluated preoperatively and at
      postoperative 1, 3, and 6 months with ultra-wide angle imaging.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity before and after surgery</measure>
    <time_frame>Changes from baseline to 1, 3, 6 months</time_frame>
    <description>Vision</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of fluids autofluorescence at the macular area</measure>
    <time_frame>Changes from baseline up to 6 months</time_frame>
    <description>Fundus autofluorescence</description>
  </secondary_outcome>
  <enrollment type="Actual">91</enrollment>
  <condition>Epiretinal Membrane</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vitrectomy with internal limiting membrane removal</intervention_name>
    <description>Vitrectomy with removal of epiretinal membrane and internal limiting membrane</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients with epiretinal membrane who underwent vitrectomy with epiretinal membrane and
        internal limiting membrane removal
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The inclusion criteria were patients who underwent vitrectomy and internal limiting
             membrane removal for epiretinal membrane and had followed for more than 6 months.

        Exclusion Criteria:

          -  The patients with follow-up less than 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Makoto Inoue, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyorin Eye Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyorin Eye Center</name>
      <address>
        <city>Mitaka</city>
        <state>Tokyo</state>
        <zip>181-8611</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2015</study_first_submitted>
  <study_first_submitted_qc>December 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyorin University</investigator_affiliation>
    <investigator_full_name>Makoto Inoue</investigator_full_name>
    <investigator_title>Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Epiretinal membrane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

